Jeff Fairman - 20 May 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
20 May 2022
Net transactions value
-$104,856
Form type
4
Filing time
24 May 2022, 16:32:59 UTC
Previous filing
09 May 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $104,856 -4,112 -1.3% $25.50 321,227 20 May 2022 By Fairman Family Trust F1
holding PCVX Common Stock 17,662 20 May 2022 Direct F2
holding PCVX Common Stock 50,000 20 May 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 1,033 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.